Sanofi's CFO search lasted two months and led the company to a financial executive from French automaker PSA Group.

Allergan is in the middle of making some moves to revive its struggling shares. And the success of its pipeline could dictate its next moves, analysts say.…

With impressive new survival data in hand, Bristol-Myers Squibb and AbbVie could land a new indication for Empliciti.

Wells Fargo analyst depicted the rejection as “a major setback” for Valeant that puts a dent in the company’s five-year growth plan.

Another week, another dismal pharma trust and reputation poll. This time, the poll comes from the Reputation Institute.

Allergan is keeping the birth control questions coming—this time in a quiz format.

Dr. Reddy's moved ahead with an "at risk" launch of Indivior's top drug, but now a court has put the rollout on hold.

CANNES, France—Pharma keys in on opportunities to scout talent, show creative work and win awards at 2018 Cannes Lions Health.